Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03368729 |
| Title | Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Alabama at Birmingham |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | United States | Details | |
| University of Chicago | Chicago | Illinois | 60637 | United States | Details | |
| Mayo Clinic | Rochester | Minnesota | 55905 | United States | Details | |
| Montefiore | Bronx | New York | 10461 | United States | Details | |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | United States | Details | |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| University of Washington- | Seattle | Washington | 98109 | United States | Details |